Cargando…

1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD

BACKGROUND: Persons who use drugs (PWUD) admitted for serious infections face many challenges when long courses of intravenous (IV) antibiotics are recommended. OPTIONS-DC is a structured multidisciplinary care conference used to navigate some of these challenges with harm reduction principles to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglass, Alyse H, Mayer, Heather, Young, Kathleen, Streifel, Amber C, Franklin, Heather, Strnad, Luke, Makadia, Jina T, Sikka, Monica K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752502/
http://dx.doi.org/10.1093/ofid/ofac492.1392
_version_ 1784850739724550144
author Douglass, Alyse H
Mayer, Heather
Young, Kathleen
Streifel, Amber C
Franklin, Heather
Strnad, Luke
Makadia, Jina T
Sikka, Monica K
author_facet Douglass, Alyse H
Mayer, Heather
Young, Kathleen
Streifel, Amber C
Franklin, Heather
Strnad, Luke
Makadia, Jina T
Sikka, Monica K
author_sort Douglass, Alyse H
collection PubMed
description BACKGROUND: Persons who use drugs (PWUD) admitted for serious infections face many challenges when long courses of intravenous (IV) antibiotics are recommended. OPTIONS-DC is a structured multidisciplinary care conference used to navigate some of these challenges with harm reduction principles to consider patient preferences, decrease length of stay when safe, and support successful completion of antibiotics(1). We aimed to describe antibiotic course outcomes 4 years after implementation of OPTIONS-DC. METHODS: We conducted a retrospective review of patients who had an OPTIONS-DC from February 2018 to February 2022. Any PWUD diagnosed with a serious infection requiring > 2 weeks of IV antibiotic treatment were eligible for an OPTIONS-DC. Data was collected via a REDCap database. R version 3.3.2 (R Core Team, 2016) was used for statistical analysis. RESULTS: 144 conferences were included, for 129 unique patients. The mean age was 39.4 with 56.3% being male. The most common infections were bacteremia (52.8%) endocarditis (36.1%), and osteomyelitis (47.9%) with a mean recommended treatment duration of 5.62 weeks (Table 1). 87 (60.4%) patients with any substance use initiated medication assisted therapy (MAT) during admission including 74.5% (79/106) of those with opioid use disorder. 112 (77.8%) antibiotic courses were completed with 71 (63.4%) completed outpatient. Of those who initiated or continued MAT during admission, 83 (74.1%) completed antibiotic therapy. Course completion was similar for those discharged home at 84% (21/25) or to a Skilled Nursing Facility (SNF) 81.8% (9/11). All 18 patients who received antibiotics via home infusion vendor and 17 (81%) via infusion center completed their course. 39 (39.8%) patients received long acting IV antibiotics and 23 (23.5%) received oral antibiotics to complete their course. Average out of hospital antibiotic days for those who completed their course were 30.5. [Figure: see text] [Figure: see text] CONCLUSION: The OPTIONS-DC model continues to be a useful tool by incorporating harm reduction principles and patient preferences for PWUD at our hospital. Our completion rate of 77.8% and outpatient completion rate of 63.4% are higher while the patient directed discharge rate of 8.3% is lower than what is generally reported in literature for this population(2-5). DISCLOSURES: Monica K. Sikka, MD, F2G: Site research investigator.
format Online
Article
Text
id pubmed-9752502
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97525022022-12-16 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD Douglass, Alyse H Mayer, Heather Young, Kathleen Streifel, Amber C Franklin, Heather Strnad, Luke Makadia, Jina T Sikka, Monica K Open Forum Infect Dis Abstracts BACKGROUND: Persons who use drugs (PWUD) admitted for serious infections face many challenges when long courses of intravenous (IV) antibiotics are recommended. OPTIONS-DC is a structured multidisciplinary care conference used to navigate some of these challenges with harm reduction principles to consider patient preferences, decrease length of stay when safe, and support successful completion of antibiotics(1). We aimed to describe antibiotic course outcomes 4 years after implementation of OPTIONS-DC. METHODS: We conducted a retrospective review of patients who had an OPTIONS-DC from February 2018 to February 2022. Any PWUD diagnosed with a serious infection requiring > 2 weeks of IV antibiotic treatment were eligible for an OPTIONS-DC. Data was collected via a REDCap database. R version 3.3.2 (R Core Team, 2016) was used for statistical analysis. RESULTS: 144 conferences were included, for 129 unique patients. The mean age was 39.4 with 56.3% being male. The most common infections were bacteremia (52.8%) endocarditis (36.1%), and osteomyelitis (47.9%) with a mean recommended treatment duration of 5.62 weeks (Table 1). 87 (60.4%) patients with any substance use initiated medication assisted therapy (MAT) during admission including 74.5% (79/106) of those with opioid use disorder. 112 (77.8%) antibiotic courses were completed with 71 (63.4%) completed outpatient. Of those who initiated or continued MAT during admission, 83 (74.1%) completed antibiotic therapy. Course completion was similar for those discharged home at 84% (21/25) or to a Skilled Nursing Facility (SNF) 81.8% (9/11). All 18 patients who received antibiotics via home infusion vendor and 17 (81%) via infusion center completed their course. 39 (39.8%) patients received long acting IV antibiotics and 23 (23.5%) received oral antibiotics to complete their course. Average out of hospital antibiotic days for those who completed their course were 30.5. [Figure: see text] [Figure: see text] CONCLUSION: The OPTIONS-DC model continues to be a useful tool by incorporating harm reduction principles and patient preferences for PWUD at our hospital. Our completion rate of 77.8% and outpatient completion rate of 63.4% are higher while the patient directed discharge rate of 8.3% is lower than what is generally reported in literature for this population(2-5). DISCLOSURES: Monica K. Sikka, MD, F2G: Site research investigator. Oxford University Press 2022-12-15 /pmc/articles/PMC9752502/ http://dx.doi.org/10.1093/ofid/ofac492.1392 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Douglass, Alyse H
Mayer, Heather
Young, Kathleen
Streifel, Amber C
Franklin, Heather
Strnad, Luke
Makadia, Jina T
Sikka, Monica K
1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title_full 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title_fullStr 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title_full_unstemmed 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title_short 1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
title_sort 1762. a review of antibiotic outcomes data utilizing the multidisciplinary options-dc conference for pwud
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752502/
http://dx.doi.org/10.1093/ofid/ofac492.1392
work_keys_str_mv AT douglassalyseh 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT mayerheather 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT youngkathleen 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT streifelamberc 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT franklinheather 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT strnadluke 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT makadiajinat 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud
AT sikkamonicak 1762areviewofantibioticoutcomesdatautilizingthemultidisciplinaryoptionsdcconferenceforpwud